Compounds > tobramycin
Page last updated: 2024-08-23

tobramycin and Vestibular Diseases

tobramycin has been researched along with Vestibular Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heijerman, HG; Kingma, H; Rijntjes, E; Scheenstra, RJ; Tavy, DL1
Brey, RH; Edson, RS; McCarthy, JT; McDonald, TJ; Terrell, CL; Thibert, JM1
Ahya, VN; Bloom, RD; Blumberg, EA; Christie, JD; Doyle, AM; Kotloff, RM; Lipson, DA; Mendez, JD; Nelson, L; Pochettino, A1

Other Studies

3 other study(ies) available for tobramycin and Vestibular Diseases

ArticleYear
Vestibulotoxicity as a consequence of systemically administered tobramycin in cystic fibrosis patients.
    Acta oto-laryngologica, 2009, Volume: 129, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Caloric Tests; Cohort Studies; Cystic Fibrosis; Dizziness; Dose-Response Relationship, Drug; Electronystagmography; Female; Humans; Male; Meniere Disease; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Pseudomonas Infections; Tobramycin; Vestibular Diseases; Vestibule, Labyrinth

2009
Vestibular toxicity due to inhaled tobramycin in a patient with renal insufficiency.
    Mayo Clinic proceedings, 2004, Volume: 79, Issue:9

    Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Female; Humans; Kidney Failure, Chronic; Pseudomonas Infections; Renal Dialysis; Tobramycin; Vestibular Diseases; Vestibular Function Tests

2004
Renal and vestibular toxicity due to inhaled tobramycin in a lung transplant recipient.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:7

    Topics: Administration, Inhalation; Anti-Bacterial Agents; Female; Humans; Lung Transplantation; Middle Aged; Pseudomonas Infections; Renal Insufficiency; Tobramycin; Vestibular Diseases

2005